Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
615 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03591861 | Therapeutic Targeting of Sex Differences in Pediatric Brain Tumor Glycolysis | terminated | N/A | 2 | Washington University School of MedicineOTHER | 1 | Dec 12, 2022 | clinicaltrials |
| NCT05096286 | Simulation-Free Hippocampal-Avoidance Whole Brain Radiotherapy Using Diagnostic MRI-Based and Cone Beam Computed Tomography-Guided On-Table Adaptive Planning in a Novel Ring Gantry Radiotherapy Device | completed | N/A | 10 | Washington University School of MedicineOTHER | 1 | Nov 23, 2022 |
| clinicaltrials |
| NCT02124902 | Neoadjuvant Treatment of Triple Negative Breast Cancer Patients With Docetaxel and Carboplatin to Assess Anti-tumor Activity | terminated | Phase 2 | 148 | Washington University School of MedicineOTHER | 1 | Nov 7, 2022 | clinicaltrials |
| NCT01779050 | Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells | terminated | Phase 2 | 7 | Washington University School of MedicineOTHER | 1 | Nov 1, 2022 | clinicaltrials |
| NCT02065609 | 89ZrTrastuzumab Breast Imaging With Positron Emission Tomography | completed | Early Phase 1 | 52 | Washington University School of MedicineOTHER | 1 | Oct 13, 2022 | clinicaltrials |
| NCT03883919 | Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based Therapy | completed | Phase 1 | 20 | Washington University School of MedicineOTHER | 1 | Oct 5, 2022 | clinicaltrials |
| NCT04741503 | Project Insight: Feasibility of a Breast Cancer Screening Decision Support Tool | completed | N/A | 1,277 | Washington University School of MedicineOTHER | 1 | Sep 28, 2022 | clinicaltrials |
| NCT04397016 | Cost Talk: Discussing Cancer Care Costs | completed | N/A | 117 | Washington University School of MedicineOTHER | 1 | Sep 26, 2022 | clinicaltrials |
| NCT03417570 | Cap Assisted Upper Endoscopy Versus High Definition White Light Endoscopy and Narrow Band Imaging Alone In The Detection Of Visible Lesions Barrett's Esophagus: A Randomized Tandem Study | terminated | N/A | 100 | Washington University School of MedicineOTHER | 1 | Sep 1, 2022 | clinicaltrials |
| NCT05018325 | Assessing Effect of Withdrawal Time on Adenoma Detection Rate for Screening Colonoscopy | terminated | N/A | 32 | Washington University School of MedicineOTHER | 1 | Aug 31, 2022 | clinicaltrials |
| NCT04623190 | Using Health Information Technology to Improve Health Behaviors and Promote Cardiovascular Health Among Adolescent and Young Adult Cancer Survivors | completed | N/A | 26 | Washington University School of MedicineOTHER | 1 | Aug 25, 2022 | clinicaltrials |
| NCT01525069 | Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma | terminated | Phase 1 | 27 | Washington University School of MedicineOTHER | 1 | Aug 10, 2022 | clinicaltrials |
| NCT01780961 | Esophageal Cancer Tissue Banking(ESBX) | completed | — | 311 | Washington University School of MedicineOTHER | 1 | Aug 9, 2022 | clinicaltrials |
| NCT03532217 | Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer | completed | Phase 1 | 19 | Washington University School of MedicineOTHER | 1 | Aug 5, 2022 | clinicaltrials |
| NCT03713021 | TraceIT Tissue Marker to Mark the Primary Resection Bed Margins of Oropharyngeal Cancers | terminated | N/A | 27 | Washington University School of MedicineOTHER | 1 | Jul 12, 2022 | clinicaltrials |
| NCT05275361 | Utilizing Social Contacts to Facilitate Mammogram Screening Among African American Women | completed | N/A | 156 | Washington University School of MedicineOTHER | 1 | Jul 7, 2022 | clinicaltrials |
| NCT03903640 | Optune Device - TT Field Plus Nivolumab and Ipilimumab for Melanoma With Brain Metastasis | terminated | Phase 2 | 2 | Washington University School of MedicineOTHER | 1 | Jun 7, 2022 | clinicaltrials |
| NCT03063203 | Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia | terminated | Phase 2 | 17 | Washington University School of MedicineOTHER | 1 | Jun 2, 2022 | clinicaltrials |
| NCT01741480 | Early Warning System | completed | N/A | 571 | Washington University School of MedicineOTHER | 1 | May 11, 2022 | clinicaltrials |
| NCT04008537 | Daily Imaging, Target Identification, and Simulated Computed Tomography-Based Stereotactic Adaptive Radiotherapy Workflow in a Novel Ring Gantry Radiotherapy Device | completed | N/A | 37 | Washington University School of MedicineOTHER | 1 | Apr 19, 2022 | clinicaltrials |
| NCT01670877 | Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer | completed | Phase 2 | 56 | Washington University School of MedicineOTHER | 2 | Apr 15, 2022 | clinicaltrials |
| NCT03916796 | Rehabilitation and Quality of Life Assessment for Soft Tissue Sarcoma Treated With Radiotherapy and Surgery | terminated | N/A | 10 | Washington University School of MedicineOTHER | 1 | Apr 12, 2022 | clinicaltrials |
| NCT04324645 | Active Symptom Monitoring in Patients Undergoing Radiation Therapy for Thoracic Malignancies | completed | — | 36 | Washington University School of MedicineOTHER | 1 | Apr 4, 2022 | clinicaltrials |
| NCT03977311 | MR-Guided High-Intensity Focused Ultrasound in Conjunction With Radiation Therapy for the Treatment of Locally Advanced Cervical Cancer | withdrawn | N/A | 0 | Washington University School of MedicineOTHER | 0 | Apr 1, 2022 | clinicaltrials |
| NCT01790035 | Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer(LGG) | terminated | Phase 1 | 23 | Washington University School of MedicineOTHER | 1 | Mar 16, 2022 | clinicaltrials |
| NCT04893915 | Cytokine-induced Memory-like NK Cells in Relapsed/Refractory AML and MDS | withdrawn | Phase 2 | 0 | Washington University School of MedicineOTHER | 0 | Mar 11, 2022 | clinicaltrials |
| NCT02427581 | Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients With Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy | withdrawn | Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | Mar 10, 2022 | clinicaltrials |
| NCT03254394 | Lidocaine for Oxaliplatin-induced Neuropathy | completed | Phase 1 / Phase 2 | 26 | Washington University School of MedicineOTHER | 1 | Mar 9, 2022 | clinicaltrials |
| NCT02086604 | Brentuximab Vedotin and Lenalidomide for Relapsed or Refractory Diffuse Large B-cell Lymphoma | completed | Phase 1 | 37 | Washington University School of MedicineOTHER | 1 | Feb 17, 2022 | clinicaltrials |
| NCT04150692 | Escalation of Daratumumab Frequency Following Biochemical Progression in Relapsed/Refractory Multiple Myeloma | withdrawn | Phase 2 | 0 | Washington University School of MedicineOTHER | 0 | Jan 24, 2022 | clinicaltrials |
| NCT04757090 | 89Zr-Trastuzumab PET/CT in Subjects With Previously Treated HER2-Positive Solid Tumors Scheduled to Receive Treatment With MT-5111 | withdrawn | Phase 2 | 0 | Washington University School of MedicineOTHER | 0 | Dec 23, 2021 | clinicaltrials |
| NCT04105062 | LS301 Uptake in Tumors of Patients Undergoing Liver, Pancreas, or Gastric Surgery | withdrawn | Phase 1 / Phase 2 | 0 | Washington University School of MedicineOTHER | 0 | Dec 9, 2021 | clinicaltrials |
| NCT04133415 | Palliative Lattice Stereotactic Body Radiotherapy (SBRT) | completed | N/A | 20 | Washington University School of MedicineOTHER | 1 | Nov 22, 2021 | clinicaltrials |
| NCT05007769 | Ramucirumab, Atezolizumab and N-803 After Progression on Any Immune Checkpoint Blocker in NSCLC(RAN) | withdrawn | Phase 2 | 0 | Washington University School of MedicineOTHER | 0 | Nov 5, 2021 | clinicaltrials |
| NCT03422094 | Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma | terminated | Phase 1 | 3 | Washington University School of MedicineOTHER | 1 | Oct 27, 2021 | clinicaltrials |
| NCT01714128 | FES-PET for Patients Treated on NCI Protocol 8762 | withdrawn | N/A | 0 | Washington University School of MedicineOTHER | 1 | Oct 25, 2021 | clinicaltrials |
| NCT02907918 | Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer(PALTAN) | terminated | Phase 2 | 26 | Washington University School of MedicineOTHER | 1 | Sep 29, 2021 | clinicaltrials |
| NCT03607955 | Paclitaxel + Carboplatin With AVB-S6-500 in Women With Stage III or IV Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Receiving Neoadjuvant Chemotherapy | withdrawn | Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | Sep 29, 2021 | clinicaltrials |
| NCT01851733 | MRI-Guided Laser Surgery and Doxorubicin Hydrochloride in Treating Patients With Recurrent Glioblastoma Multiforme | completed | Phase 1 | 37 | Washington University School of MedicineOTHER | 1 | Aug 27, 2021 | clinicaltrials |
| NCT04437472 | Remote Collection of Patient Reported Toxicity Using SMS Text Messaging (CareSignal) | completed | — | 30 | Washington University School of MedicineOTHER | 1 | Aug 25, 2021 | clinicaltrials |
| NCT02546531 | Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer | completed | Phase 1 | 43 | Washington University School of MedicineOTHER | 1 | Jul 20, 2021 | clinicaltrials |
| NCT01784861 | VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors | terminated | Phase 1 / Phase 2 | 23 | Washington University School of MedicineOTHER | 1 | Jul 8, 2021 | clinicaltrials |
| NCT03982004 | Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer | terminated | Phase 1 | 1 | Washington University School of MedicineOTHER | 1 | Jun 21, 2021 | clinicaltrials |
| NCT03068832 | Neoepitope-based Personalized Vaccine Approach in Pediatric Patients With Recurrent Brain Tumors | withdrawn | Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | May 25, 2021 | clinicaltrials |
| NCT02608229 | BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer | terminated | Phase 1 | 18 | Washington University School of MedicineOTHER | 1 | Apr 21, 2021 | clinicaltrials |
| NCT02562027 | SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer | completed | N/A | 217 | Washington University School of MedicineOTHER | 1 | Apr 8, 2021 | clinicaltrials |
| NCT03958253 | Lung Cancer Screening Protocol(I-STEP) | completed | N/A | 193 | Washington University School of MedicineOTHER | 1 | Apr 8, 2021 | clinicaltrials |
| NCT03457454 | Reducing Rural Colon Cancer Disparities | completed | — | 431 | Washington University School of MedicineOTHER | 1 | Apr 1, 2021 | clinicaltrials |
| NCT01692587 | Does Protein Restriction Inhibit Prostrate Cancer Growth | completed | N/A | 65 | Washington University School of MedicineOTHER | 1 | Mar 26, 2021 | clinicaltrials |
| NCT01207921 | Lenalidomide Maintenance Therapy Post Autologous Transplant for Hodgkins Lymphoma | completed | Phase 1 | 28 | Washington University School of MedicineOTHER | 1 | Mar 10, 2021 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials